In clinical studies, Taxotere® (docetaxel) has been shown to be beneficial for several types of cancer, including:
- Breast cancer
- Non-small cell lung cancer (NSCLC)
- Prostate cancer
- Stomach cancer (gastric cancer)
- Head and neck cancer.
Many studies have been done to prove the benefits of Taxotere. For example, one study looked at using the drug for nonoperable NSCLC that had not responded to previous chemotherapy. Compared to supportive care (which is care to improve the quality of life but not to treat the cancer), Taxotere extended the survival time and delayed the progression of the cancer.
(To learn more about the benefits of this chemotherapy drug, click Taxotere. This article provides more information on how it works, what to discuss with your healthcare provider, and what to expect during treatment.)